
© 2025 ARIVA.de
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Di | As Humira succession plan played out, AbbVie's Rob Michael collected $18.5M in his first year as CEO | ||
Di | With AbbVie in its sights, Tenpoint names commercial chief ahead of vision drug launch | ||
Di | Xilio advances cancer treatments, secures AbbVie collaboration | ||
Di | 42,395 Shares in AbbVie Inc. (NYSE:ABBV) Acquired by Natural Investments LLC | ||
Di | AbbVie Inc. (ABBV): A Magnificent Dividend Growth Stock to Invest In |